These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26498868)

  • 1. Validation of the Seattle Heart Failure Model in Japanese heart failure patients.
    Shiraishi Y; Sawano M; Kohno T; Nishiyama T; Maekawa Y; Sano M; Fukuda K; Kohsaka S
    Int J Cardiol; 2016 Jan; 203():87-9. PubMed ID: 26498868
    [No Abstract]   [Full Text] [Related]  

  • 2. The Seattle Heart Failure Model: prediction of survival in heart failure.
    Levy WC; Mozaffarian D; Linker DT; Sutradhar SC; Anker SD; Cropp AB; Anand I; Maggioni A; Burton P; Sullivan MD; Pitt B; Poole-Wilson PA; Mann DL; Packer M
    Circulation; 2006 Mar; 113(11):1424-33. PubMed ID: 16534009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of mode of death in heart failure: the Seattle Heart Failure Model.
    Mozaffarian D; Anker SD; Anand I; Linker DT; Sullivan MD; Cleland JG; Carson PE; Maggioni AP; Mann DL; Pitt B; Poole-Wilson PA; Levy WC
    Circulation; 2007 Jul; 116(4):392-8. PubMed ID: 17620506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-variable risk model in men and women with heart failure.
    Chyu J; Fonarow GC; Tseng CH; Horwich TB
    Circ Heart Fail; 2014 Jan; 7(1):88-95. PubMed ID: 24281135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM).
    Goda A; Williams P; Mancini D; Lund LH
    J Heart Lung Transplant; 2011 Nov; 30(11):1236-43. PubMed ID: 21764604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study.
    Lassus J; Gayat E; Mueller C; Peacock WF; Spinar J; Harjola VP; van Kimmenade R; Pathak A; Mueller T; Disomma S; Metra M; Pascual-Figal D; Laribi S; Logeart D; Nouira S; Sato N; Potocki M; Parenica J; Collet C; Cohen-Solal A; Januzzi JL; Mebazaa A;
    Int J Cardiol; 2013 Oct; 168(3):2186-94. PubMed ID: 23538053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation.
    Sartipy U; Goda A; Yuzefpolskaya M; Mancini DM; Lund LH
    Am Heart J; 2014 Sep; 168(3):325-31. PubMed ID: 25173544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A time to be born and a time to die.
    Goldberg LR; Jessup M
    Circulation; 2007 Jul; 116(4):360-2. PubMed ID: 17646592
    [No Abstract]   [Full Text] [Related]  

  • 9. Validation of mortality risk stratification models for cardiovascular disease.
    Nakayama M; Osaki S; Shimokawa H
    Am J Cardiol; 2011 Aug; 108(3):391-6. PubMed ID: 21600539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification in acute heart failure.
    Lee DS; Ezekowitz JA
    Can J Cardiol; 2014 Mar; 30(3):312-9. PubMed ID: 24565256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyposmolarity may be also associated with worse outcomes in patients with heart failure.
    Shen Y; Du K
    Int J Cardiol; 2017 Feb; 229():53. PubMed ID: 27865663
    [No Abstract]   [Full Text] [Related]  

  • 12. Usefulness of the Seattle Heart Failure Model to identify adults with congenital heart disease at high risk of poor outcome.
    Stefanescu A; Macklin EA; Lin E; Dudzinski DM; Johnson J; Kennedy KF; Jacoby D; DeFaria Yeh D; Lewis GD; Yeh RW; Liberthson R; Lui G; Bhatt AB
    Am J Cardiol; 2014 Mar; 113(5):865-70. PubMed ID: 24411285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double Vision: Replicating a Trial Showing a Survival Benefit.
    Packer M
    JACC Heart Fail; 2017 Mar; 5(3):232-235. PubMed ID: 28254131
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk stratification by T-wave morphology for cardiovascular mortality in patients with systolic heart failure.
    Huang HC; Lin LY; Yu HY; Ho YL
    Europace; 2009 Nov; 11(11):1522-8. PubMed ID: 19819880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic index to determine the impact of cardiac conditions and co-morbidities on one-year outcome in patients with heart failure.
    Senni M; Santilli G; Parrella P; De Maria R; Alari G; Berzuini C; Scuri M; Filippi A; Migliori M; Minetti B; Ferrazzi P; Gavazzi A
    Am J Cardiol; 2006 Oct; 98(8):1076-82. PubMed ID: 17027575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Seattle Heart Failure Model (SHFM) in heart failure population.
    Hussain S; Kayani AM; Munir R; Abid I
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):153-6. PubMed ID: 24613107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish heart failure registry.
    Sartipy U; Dahlström U; Edner M; Lund LH
    Eur J Heart Fail; 2014 Feb; 16(2):173-9. PubMed ID: 24464911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram.
    Barlera S; Tavazzi L; Franzosi MG; Marchioli R; Raimondi E; Masson S; Urso R; Lucci D; Nicolosi GL; Maggioni AP; Tognoni G;
    Circ Heart Fail; 2013 Jan; 6(1):31-9. PubMed ID: 23152490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials to "real-world" heart failure: applying risk stratification to deliver personalized care.
    Baliga RR; Young JB
    Heart Fail Clin; 2011 Oct; 7(4):xi-xiv. PubMed ID: 21925425
    [No Abstract]   [Full Text] [Related]  

  • 20. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.
    May HT; Horne BD; Levy WC; Kfoury AG; Rasmusson KD; Linker DT; Mozaffarian D; Anderson JL; Renlund DG
    Am J Cardiol; 2007 Aug; 100(4):697-700. PubMed ID: 17697831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.